Pathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liverdiseases and disorders of thyroid homeostasis

Chympoy, K.A.; Pashkovska, N.V.; Fediv, O.I.; Pavlibroda, N.M.

dc.contributor.author	Chympoy, K.A.
dc.contributor.author	Pashkovska, N.V.
dc.contributor.author	Fediv, O.I.
dc.contributor.author	Pavlibroda, N.M.
dc.date.accessioned	2016-05-26T09:35:39Z
dc.date.available	2016-05-26T09:35:39Z
dc.date.issued	2014
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/10884
dc.description.abstract	The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases against the ground of administration of “Triovit”, a selenium-containing drug, has been studied. The administration of “Triovit” in a comprehensive therapy of patients with chronic diffuse liver diseases was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	Буковинський медичний вісник. – 2014. – Т.18, №2(70). – C.113-116.	ru_RU
dc.subject	chronic diffuse liver diseases	ru_RU
dc.subject	cellular adhesion	ru_RU
dc.subject	fibrinolysis	ru_RU
dc.subject	Triovit	ru_RU
dc.subject	хронические диффузные заболевания печени	ru_RU
dc.subject	тиреоидный гомеостаз	ru_RU
dc.subject	клеточная адгезия	ru_RU
dc.subject	фибринолиз	ru_RU
dc.subject	триовит	ru_RU
dc.subject	thyroid homeostasis	ru_RU
dc.subject	хронічні дифузні захворювання печінки	ru_RU
dc.subject	тиреоїдний гомеостаз	ru_RU
dc.subject	клітинна адгезія	ru_RU
dc.subject	фібриноліз	ru_RU
dc.subject	триовіт	ru_RU
dc.title	Pathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liverdiseases and disorders of thyroid homeostasis	ru_RU
dc.type	Article	ru_RU